baber/WOPTO huggingface dataset:
Patent ES-522114-A0 (ES)
IPC: H04N9/68
Filed: 1983-05-05
Abstract: 1. Method for the limiting of the cathode-ray current in the picture tube of a colour television receiver, in which, for the automatic operating point adjustment of the video amplifier stages (1,4; 2,5; 3,6) for the colours red, green and blue with the aid of a control circuit (10) during a plurality of lines of the invisible part of the forward picture stroke, there are applied successively in time to the inputs of the video amplifier stages reference levels by means of switches (S17, S18, S19) which are successively closed by the control circuit, and during the application of the reference levels there is taken off a signal from which is produced for each video amplifier stage an amplification control signal which is effective for the duration of the visible forward picture stroke so that the amplification of the video amplifier stages is maintained at a constant value, in which for limiting the cathode-ray current a signal is derived from the average cathode-ray current of the picture tube, characterised in that the information (ABI) for the average cathode-ray current is compared in a differential amplifier stage (23) with a reference voltage (Vref ), and the output voltage of this differential amplifier stage (23), from a predetermined value onwards of the average cathode-ray current, which value exceeds the reference voltage, raises in such a way the current of a constant-current source (8) which produces the reference level to be introduced at a resistor (9) that the automatic amplification control actuated by the raised reference level decreases the overall amplification factors of the individual output amplifiers (1,4; 2,5; 3,6) in common in the same ratio.
Patent ES-526792-A0 (ES)
IPC: B61L27/00
Filed: 1983-10-26
Abstract: Transponders are arranged at control locations associated with sections of a track or travel path. Each transponder is in wireless communication through an inductive transmission path and an optical transmission path with a conveyor present in the operable range of the transponder. Each transponder is in communication with a central system control via an associated group control unit by means of two-wire lines or conductors. The operational mode of each transponder is controllable by means of a multiplexer such that the transponder operates either as a responder or answering device with simultaneous unidirectional signal transfer and which responder is to be interrogated by a conveyor or as a bidirectional signal transmitter. The apparatus selectively functions as a location or site code transmitter and presence indicator for the individual conveyors or as bidirectional data transmitter with isolated directions between the conveyors and the central system control. Due to such dual utilization only one type of layout element is required, resulting in a high reduction in the installation expense and its maintenance. The apparatus is intended for the modular erection of conveyor installations of different sizes and output and is equally well suited for partially autonomous as well as for central control of the conveyors.
Patent ES-528899-A0 (ES)
IPC: A23L35/00
Filed: 1984-01-16
Abstract: The present invention relates to a multiple soft capsule in which a soft capsule is contained in another soft capsule and the production thereof. The multiple soft capsule is useful for various industrial fields such as medicine, foods, table luxuries and the like. Especially, the multiple capsule is useful in medical field, for instance, in combining two or more components which cannot be enclosed together in a single capsule or in the dissolution control in vivo of the medicines by properly selecting the kind of the film-forming substance for the outer and inner soft capsules.
Patent ES-532645-A0 (ES)
IPC: A61K9/22
Filed: 1984-05-18
Abstract: Compression gradient tablets are described which provide for controlled release of active ingredient.
Patent ES-547587-A0 (ES)
IPC: C11D3/386
Filed: 1985-09-12
Abstract: Compositions effective in removing protein, fat and/or starch based stains as well as oil and grease based stains from fabrics comprise organic solvents admixed with surfactants and an enzyme component wherein the enzymes are dissolved in aqueous solution and the aqueous solution is, in turn, dispersed as reversed micelles within the solvent surfactant mixture. Encapsulating the enzymes in reversed micelles protects them from degradation by the solvents and thereby prolongs the effectiveness of the enzymes for extended periods of time. The total water content of the compositions is kept below 5 weight% so that the compositions' oil and grease stain removal ability remains unimpaired.
Patent ES-553740-A0 (ES)
IPC: B65D33/30
Filed: 1986-04-04
Abstract: Material and method for making three reclosable bag sections from separable fastener equipped web, comprising folding opposite free portions of the web upon themselves and folding an intervening portion of the web upon itself and thereby providing three bag sections in a generally Y orientation. Separably interlockable fastener profiles adjacent to juncture of the three sections being arranged to provide a respective bag top separable profile fastener assembly along each of the bag sections. The bag sections are separable from one another at the juncture. Pull flanges may be provided along the separable fastener assembly of each of the sections.
Patent ES-555256-A0 (ES)
IPC: B24B23/04
Filed: 1986-05-23
Abstract: An orbital sander/grinder has on one side of its housing a rotatably mounted disk holder which is brought into orbital motion by means of a drive mechanism that is inside the housing, and is coupled with an eccenter. The eccenter is rotatably mounted on one side in the housing, on the other side in the disk holder, while the rotational axis in the housing is radially offset relative to the rotational axis of the eccenter in the disk holder, but the two axes run parallel to each other. A balancing weight for compensating the unbalance rotates in synchronization with the eccenter. To ensure sanding/grinding with a minimum of vibration, means are provided to compensate for the transverse forces generated by the abrasive and/or cutting forces that are exerted at the eccenter.
Patent ES-555671-A0 (ES)
IPC: C07D457/02
Filed: 1986-06-03
Abstract: Ergoline derivatives of the formula Iwherein R<sub>1</sub>=H, CH<sub>3</sub>; R<sub>2</sub>=H, halogen, CH<sub>3</sub>, CN, C<sub>1</sub>-C<sub>4</sub> alkylthio or phenylthio; R<sub>3</sub>=C<sub>1</sub>-C<sub>4</sub> hydrocarbon; R<sub>4</sub>=H, OCH<sub>3</sub>; R<sub>5</sub>=H and R<sub>6</sub>=-CH=CH-CONHR<sub>7</sub> or R<sub>5</sub> + R<sub>6=</sub> =CH-CONHR<sub>7</sub>; R<sub>7=</sub> 2-thiazolyl, 3-pyridazinyl, 1,3,4-thiadiazol-2-yl or 4-pyrimidinyl group optionally substituted, and pharmaceutically acceptable salts thereof, display activity on the Central Nervous System and are useful as antiprolactinic agents. Their preparation, pharmaceutical compositions containing them, and their use in the preparation of a medicament for the treatment of Parkinson's disease are also described.
Patent ES-556551-A0 (ES)
IPC: C07D281/10
Filed: 1986-06-24
Abstract: Novel 1,5-benzothiazepine derivatives of the formula:wherein R' and R<sup>4</sup> are:a) R<sup>1</sup> is lower alkyl or lower alkoxy, and R<sup>4</sup> is lower alkyl, lower alkoxy, fluorine, benzyloxy, hydroxy or lower alkylthio, orb) R' is lower alkyl, and R<sup>4</sup> is hydrogen, orc) R' is hydroxy, and R<sup>4</sup> is lower alkyl, fluorine, hydroxy or lower alkylthio;R<sup>2</sup> is hydrogen, lower alkanoyl or benzoyl; and R<sup>3</sup> is lower alkyl; and a pharmaceutically acceptable acid addition salt thereof are disclosed. In form of pharmaceutical compositions the said derivative (I) and its salt have a potent platelet aggregation-inhibiting activity.
Patent ES-557153-A0 (ES)
IPC: C07D407/12
Filed: 1986-10-30
Abstract: The present invention relates to novel labdanes, intermediates and processes for the preparation thereof. The compounds have the ability to reduce elevated intraocular pressure and can, therefore, be used as medicaments.
Patent ES-557433-A0 (ES)
IPC: G01M3/00
Filed: 1987-03-02
Abstract: PCT No. PCT/CH86/00043 Sec. 371 Date Feb. 6, 1987 Sec. 102(e) Date Feb. 6, 1987 PCT Filed Apr. 9, 1986 PCT Pub. No. WO86/06166 PCT Pub. Date Oct. 23, 1986.In order to improve existent methods for measuring the sealing of tanks (1), the temperature ( theta 1) of the tank is measured when taking up a magnitude relative to the pressure (p) representative of a leak. A predetermined magnitude relative to a limit pressure (pG) to decide whether a tank fulfils the required sealing conditions at a temperature ( theta 2) is calculated for a measurement temperature ( theta 1); the actual pressure value and the limit or ultimate pressure value at this measurement temperature ( theta 1) are then compared. Thereby, pressure variations due to temperature variations are taken into account.
Patent FI-870970-A0 (FI)
Inventor: MOSIMANN PETER
IPC: G08B17/02
Filed: 1987-03-05
Abstract: 1. Fire alarm installation, particularly for a road tunnel, comprising a light source (5; 50), an optical fibre (2; 20), means for producing microcurves (1, 4; 21, 22, 23) of the fibre dependent upon the temperature on the fibre, and a detector (6; 60) intended to measure the light diffused back by the fibre, characterized in that the means for producing microcurves dependent upon the temperature comprise tubes (1) closed at their ends for temperature-pressure transduction, in that each tube is connected to a jaw (4) provided with teeth, and in that the optical fibre (2) passes between the teeth of the jaws (4).
Patent FI-872901-A0 (FI)
Inventor: PACHERNEGG RUDOLF
IPC: C12G3/00
Filed: 1987-07-01
Abstract: PCT No. PCT/AT86/00070 Sec. 371 Date Jul. 1, 1987 Sec. 102(e) Date Jul. 1, 1987 PCT Filed Nov. 4, 1986 PCT Pub. No. WO87/02699 PCT Pub. Date May 7, 1987.In a process of producing a carbonated hop-malt beverage in which a wort concentrate is produced from malt extract, hop concentrate and yeast by a heat treatment, fermentation, filtration and pasteurization, the wort concentrate is packaged for a long shelf life and for the consumption of the beverage is diluted with water and carbon dioxide, it is desired to produce a beverage which in its taste and consistency and particularly as regards frothing is similar to conventional beer. This is accomplished in that in the preparation of the wort concentrate from dilute malt extract, protein is separated by being heated and precipitated and hop concentrate and yeast are added to the resulting liquor, which is subsequently fermented. After an optional addition of nutrients and aromas to the liquor the fermentation is interrupted by shock cooling. The substrate is filtered, pasteurized and packaged. To produce the potable beverage that wort concentrate may be supplied at a controlled rate to a mixing stage, in which the wort concentrate is continuously diluted with CO2-containing water and can finally be dispensed under superatmospheric pressure.
Patent FI-895765-A0 (FI)
Inventor: VALLE FRANCESCO DELLA
IPC: C07H15/10
Filed: 1989-12-01
Abstract: Novel N-acyl-lysogangliosides obtained from gangliosides by deacyation of the ceramide group, wherein the acyl group is derived from an aliphatic acid having from 2 to 24 carbon atoms, substituted by one or more polar groups. The N-acyl-lysogangliosides of the invention exhibit an inhibiting action on protein-kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system.
Patent FI-896206-A0 (FI)
Inventor: HOPPERDIETZEL SIEGFRIED
IPC: E03F3/04
Filed: 1989-12-22
Abstract: The invention relates to a pipe joint for propulsion pipes or the like, having joining regions on the respectively free ends (111) of the individual pipes (1, 2). To form these joining regions, the pipe wall is set back on at least one free end (111), in steps of corresponding length and depth as a mirror image of the free end of the meeting pipe which overlaps it. According to the invention, annular supporting elements (3, 4), located opposite the steps formed by the insertion end (11) and by the socket end (21), are arranged in mirror image form, or are offset with respect to one another, on the outer and inner circumference respectively of the insertion end (11) and of the socket end (21).
Patent FI-903972-A0 (FI)
Inventor: TOTH EDIT
IPC: A61K31/335
Filed: 1990-08-10
Abstract: The invention relates to 1-oxa-2-oxo-8-azasprio [4,5]decane derivatives of formula (I), <CHEM>  wherein  X represents an oxygen atom or an NR group,  wherein R represents a hydrogen atom or a C1-12 alkyl or C3-6 cycloalkyl group, or a carbocyclic C6-10 aryl or carbocyclic C6-10 aryl-C1-14 alkyl group optionally substituted on the aromatic ring by one or more halogen atoms, C1-4 alkyl or C1-4 alkoxy groups; R<1> and R<2> together represent a methylene group or, when X is a NR group, one of R<1> and R<2> additionally represents a hydroxyl group and the other additionally represents a methyl group; R<3> represents a hydrogen atom or a phenyl group optionally substituted by one or more halogen atoms, C1-4 alkyl, C1-4 alkoxy or hydroxyl group; Ph represents a phenyl group unsubstituted or substituted by one or more halogen atoms, C1-4 alkyl, C1-4 alkoxy, hydroxyl or trihalomethyl groups; and  n is 1, 2, 3; and optical isomers and mixtures thereof and all acid addition and quaternary ammonium salts thereof. The invention further relates to pharmaceutical compositions containing these compounds and processes for their preparation. The compounds of formula (I) possess calcium, uptake-inhibiting, antihypoxic and antianoxic properties and a low toxicity. Thus, they are useful for the treatment of brain damage of various origin.
Patent FI-913433-A0 (FI)
Inventor: VAN BELLE HERMAN
IPC: A61P43/00
Filed: 1991-07-16
Abstract: The compound (l)-(-)-2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-[5,5-bis(4- fluorophenyl)pentyl]-1- piperazineacetamide, the pharmaceutically acceptable acid addition salts thereof or hydrates thereof; <CHEM> a process of preparing said compound and pharmaceutical compositions comprising said compound as an active ingredient.
Patent FI-915916-A0 (FI)
Inventor: PARKER DAVID
IPC: C07F9/6524
Filed: 1991-12-16
Abstract: Metal complex of tetra-aza macrocycles of formula (1) <CHEM> wherein Alk<1>, Alk<2>, Alk<3> and Alk<4>, which may be the same or different, is each a C1-4alkylene chain optionally substituted by one or more optionally substituted C1-6alkyl groups; and R<1>, R<2>, R<3> and R<4> which may be the same or different is each a hydrogen atom or a group AlkR<5> where Alk is an optionally substituted straight or branched C1-6alkyl group R<5> is a hydrogen atom or a -CO2H, -CONR<6>R<7> [where R<6> and R<7>, which may be the same or different, is each a hydrogen atom or C1-6alkyl group] or -P(X<1>) (X<2>R<8>)R<9> group where X<1> and X<2>, which may be the same or different is each an oxygen or sulphur atom, R<8> is a hydrogen atom or an alkyl group and R<9> is an alphatic, aromatic or heteroaromatic group, with the proviso that at least two of R<1>, R<2>, R<3> and R<4> is a group -Alk P(X<1>) (X<2>R<8>)R<9> or one R<1>, R<2>, R<3> and R<4> is a group -Alk P(X<1>) (X<2>R<8>)R<9> and at least one of the remaining groups R<1>, R<2>, R<3> and R<4> is a group -AlkCO2H or -AlkCONR<6>R<7>, or a salt thereof, for use as contrast agents in nuclear magnetic resonance imaging are described.
Patent FI-921069-A0 (FI)
Inventor: JENDRALLA JOACHIM-HEINER
IPC: C07C269/06
Filed: 1992-03-12
Abstract: A method is described for the preparation of optically pure symmetric compounds of the formula I <IMAGE> in which R<1>, R<2> and R<3> are described in the description, with the simultaneous control of the four centres of chirality identified with <*>.
Patent FI-922404-A0 (FI)
Inventor: ROSAMOND JAMES DONALD
IPC: C07K1/06
Filed: 1992-05-26
Abstract: Compounds of formula (I), wherein M is Met, DMet, MeMet, MetO, Ahx, DAhx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala or Lys; G is Gly, DAla, Pro, Ala,  beta Ala or Sar; W is Trp, MeTrp, Ala or Nal; X is Met, MeMet, MetO, Ahx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala or Lys; J is Asp, DAsp, MeAsp, Ala or Asn; F<1> is (S)-NH, (R)-NH, (S)-R<1>N or (R)-R<2>N; F<2> is H, Cl, I, Br, F, NO2, NH2, R<3> or OR<4>; Z is NH2, NHR<5> or NR<5>R<6>; R<1>, R<2>, R<3>, R<5> and R<6> are C1 to 6 alkyl; and R<4> is H or C1 to 6 alkyl, and pharmaceutically acceptable salts thereof, are new and useful as pharmaceuticals. In particular they are useful for the treatment of obesity and for stimulating contraction of the gall bladder.
Patent FI-922563-A0 (FI)
Inventor: ANGELONE PHILIP P JR
IPC: A61K8/894
Filed: 1992-06-03
Abstract: A clear gel-type cosmetic product has a viscosity of at least about 50,000 cps at 21 DEG  C., and includes an emulsion with an oil phase and a water phase that includes an incorporated active ingredient. The refractive indices of the water and oil phases match to at least 0.0004, the refractive index of the product is about 1.4000, and the product clarity is better than thirty NTU.
Patent FI-923124-A0 (FI)
Inventor: HERRMANN PETER
IPC: A61P31/04
Filed: 1992-07-07
Abstract: A method for preparing purified ribonuclease dimers is provided which comprise the steps of dimerizing monomeric ribonuclease with a suberimidate coupling reagent, filtering out undimerized monomers and oligomers from the dimer solution using a series of ion exchange resin chromatography steps, monitoring the progress of the reaction through gel electrophoresis, and collecting the purified ribonuclease dimer product. The method is advantageous in that large amounts of the dimeric product can be obtained efficiently and relatively inexpensively, and the ribonuclease dimers so produced can be employed for their beneficial effects in combatting viral and bacterial infections without the cytotoxic effects normally associated with the ribonuclease monomer.
Patent FI-925093-A0 (FI)
Inventor: FROMMELT MARKUS
IPC: B25C1/18
Filed: 1992-11-10
Abstract: The setting device operated by powder force has a guide passage (9) for strip-shaped cartridge magazines (8), feed means (10) and retaining means (15) being arranged which project into the guide cross-section of the guide passage (9). Blocking members (13, 14) are arranged in the entry area of the guide passage (9). By means of insertion bevels (8c, 8d) arranged on the cartridge magazine (8), the blocking members (13, 14) are pushed out of the guide cross-section of the guide passage (9) so that the cartridge magazine (8) can be pushed further into the guide passage (9) until it comes to bear against the feed means (10) or retaining means (15). 
<IMAGE>
Patent FI-952824-A0 (FI)
Inventor: MOLZEN EJNER K
IPC: C07D403/12
Filed: 1995-06-08
Abstract: Fused benzo compounds of formula I are provided, wherein A is a 2 to 6 membered hydrocarbon spacer group, B is a polar divalent group selected from a group (a); U is C, N or CH; X is a divalent 3-4 membered chain optionally comprising one or more heteroatoms; R1 is an aliphatic hydrocarbon group, arylalkyl or diphenylalkyl; R2 and R3 are hydrogen or alkyl or together form an ethylene or propylene bridge; R4, R5 and R6 are hydrogen or substituents; R7 and R8 are hydrogen or substituents including -COOR9 and -CONR10R11; are 5-HT1A receptor ligands useful in the treatment of CNS disorders. Pharmaceutical compositions comprising the compounds and their use for the manufacture of a pharmaceutical preparation are also provided.\!
Patent FI-952933-A0 (FI)
Inventor: BARTZ ARNOLD M
IPC: C08G18/00
Filed: 1995-06-14
Abstract: Disclosed is a method of insulating a surface or enclosure by applying to the surface or enclosure a polymeric foam structure of a polymer material and carbon black. The carbon black is generally uniformly dispersed in the polymer matrix in the form of discrete, individual particles substantially free of agglomeration. A preferred carbon black is thermal black. The carbon black is easily processed and integrated into the present structure, and provides a lower thermal conductivity for a given loading. Further disclosed is a process for making the foam structure. Further disclosed is an extruded, insulative foam structure of the type described above.
Patent FI-954090-A0 (FI)
Inventor: BODMER ROLAND
IPC: C12C11/09
Filed: 1995-08-31
Abstract: PCT No. PCT/EP95/02759 Sec. 371 Date Apr. 3, 1997 Sec. 102(e) Date Apr. 3, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/06923 PCT Pub. Date Mar. 7, 1996A process is for the continuous production of beer having a diacetyl content below 0.1 mg/l from a cooked, unfermented, fermentable wort with an oxygen content of 0.5 to 3.0 mg O2 per liter.
Patent FI-963355-A0 (FI)
Inventor: ROE DONALD CARROLL
IPC: A61F13/56
Filed: 1996-08-28
Abstract: Disclosed is a nonwoven web comprising a plurality of first regions and a plurality of second regions comprised of the same material and being visually distinct from each other, wherein the first regions will exhibit resistive forces in response to an applied elongation along at least one axis before a substantial portion of the second regions develop significant resistive forces to the applied elongation.
Patent FI-970385-A0 (FI)
Inventor: LANTING FEICO
IPC: A01J25/00
Filed: 1997-01-30
Abstract: Process for preparing fresh cheese having a fancy shape wherein fresh cheese is extruded through a nozzle in such condition that the shape of the product as extruded does not collapse and fancy shaped portion of fresh cheese is obtained.
Patent AP-9400663-A0 (AP)
Title: Novel compounds.
Inventor: BROOM NIGEL JOHN PARRYMAN
IPC: A01N47/12
Filed: 1994-08-10
Abstract: Derivatives of monic acid a and c have useful antibacterial, antimycoplasmal antifungal and herbicidal activity
Patent IL-69332-A0 (IL)
Title: Plant tissue culture vessel
IPC: C12M3/00
Filed: 1983-07-26
Abstract: A plant tissue culture vessel with a substantially flat fine screening element (2) elevated above the inner bottom surface (3) of the vessel, the vessel being sterilizable, substantially sealable (by a lid, not shown) and adapted for growing plant tissue cultures supported on the surface of the screening element in optimal contact with a culture medium filling the vessel to the level of the screening element (2). The screening element has a mesh size which permits the passage of the culture medium therethrough while retaining the tissue culture on the surface thereof.
Patent IL-74408-A0 (IL)
Title: Production of combustible gases from waste products
IPC: C10J3/66
Filed: 1985-02-21
Abstract: 1. Process for producing combustible gases from waste products such as household refuse, industrial refuse, old tyres, synthetic waste, purified sludge or similar, whereby the waste products are heated in a first stage in a rotating reactor with exclusion of air and carbonized at temperatures of between 300 and 700 degrees C, the low temperature carbonization gases produced are removed from the first stage and partially combusted at temperatures of 800 to 1200 degrees C in a second stage in a gas conversion reactor with conduction of oxygen-containing gases, and then are led through an incandescent layer of lumps of solid materials, the cracked gases are removed from the second stage, and the low temperature carbonization residue containing low temperature carbonization coke is removed from the first stage, characterised in that the low temperature carbonization gases removed from the first stage are substantially freed of entrained solid materials in a dry gas cleaning process and are then led through an incandescent layer of foreign coke in the second stage, one part of the foreign coke being constantly removed, cleaned and reintroduced, and whereby the low temperature carbonization residue removed from the first stage is freed by sieving of coarse-grained particles, which are conveyed for further processing in order to obtain the metal content, and is removed from the process together with the solid materials separated in the dry gas cleaning process.